Danaher Operating Cash Flow decreased by 37.6% to $1.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $1.30B to $1.32B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -6.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.12B | $2.03B | $2.33B | $1.97B | $2.00B | $2.01B | $2.54B | $1.95B | $1.93B | $1.67B | $1.62B | $1.74B | $1.42B | $1.51B | $2.02B | $1.30B | $1.34B | $1.66B | $2.12B | $1.32B |
| QoQ Change | — | -4.1% | +14.7% | -15.6% | +1.6% | +0.5% | +26.4% | -23.4% | -1.1% | -13.2% | -3.2% | +7.4% | -18.5% | +6.8% | +33.4% | -35.7% | +3.0% | +24.2% | +27.4% | -37.6% |
| YoY Change | — | — | — | — | -5.7% | -1.2% | +8.9% | -1.1% | -3.7% | -16.8% | -36.3% | -10.7% | -26.4% | -9.5% | +24.7% | -25.3% | -5.6% | +9.8% | +4.9% | +1.8% |